GlobeNewswire by notified

Boyden Finds Digital Progress Puts Europe in Pole Position to Champion Industry 5.0

Share

Global research shows Industry 5.0 gathering pace as European business leaders excel in leveraging digital capabilities through human ingenuity

NEW YORK and LONDON and BERLIN, Nov. 20, 2022 (GLOBE NEWSWIRE) -- Boyden, a premier leadership and talent advisory firm with more than 75 offices in over 45 countries, reports on its annual global executive talent research. Findings show European respondents focusing on key elements of Industry 5.0, striving for growth through (i) innovation, (ii) digital transformation and (iii) human capital.

The global study, Strengthening the human-centric core of Industry 5.01, How can organisations thrive in a complex world of risk? explores perspectives on risk among CEOs, boards and other senior leaders, alongside executive talent trends, priorities and investment.

“Despite economic and geopolitical concerns, European business leaders are pressing ahead with an integrated strategy of growth through innovation and digital advances combined with human ingenuity,” comments Kathleen Dunton, Boyden board member, Managing Partner Germany and EMEA Regional Practice Leader, Private Equity & Venture Capital. “Investment in talent is spread across leadership development, hiring new leaders, retraining and interim management. In this tough environment, leaders are resilient, leveraging their most valuable soft skills identified by our respondents as driving change, inspiring teams and showing empathy.”

Findings that show how European organisations are well positioned for Industry 5.0:

  • A stronger focus than other regions on strengthening tech/cloud/cybersecurity and digital skills in 2022, consistent with 2021 findings
  • Structural change driven by digital advances and competing for the right talent, identified by 43 percent and 33 percent of respondents respectively
  • Exceptionally high confidence among respondents in the technology sector, with 94 percent very confident/confident in their organisation’s growth potential, while concerned externally about (i) geopolitical risk, (ii) industry competition and (iii) national economic volatility
  • Greater investment in leadership development of high potentials through 2023
  • Culture shifts driven by organisational agility and innovation, identified by 44 percent and 40 percent of respondents respectively
  • Overall confidence in organisational growth potential (where there is the greatest element of control) at 80% very confident/confident

Mark Soden, Managing Partner at Boyden UK and member of the global technology practice adds, “Despite the economic and geopolitical headwinds, it is no surprise that the technology sector continues to remain confident; customer demand is strong and there is still plenty of investor appetite. While some areas of technology may face a challenging 2023 there will be pockets of the sector that continue to thrive.”

An increase in senior-level recruitment is expected through 2023, up from 35 percent of respondents in the 2021 study to 52 percent in 2022, correlating with human capital as the third top driver of growth. Recruitment challenges are expected by 64 percent compared with 48 percent in 2021, with an expected increase in the use of interim managers; 36 percent of respondents are extremely likely/likely to bring in interim executives in Europe, up from 22 percent in 2021. Financial services is the sector most likely to increase engagement of interims.

Lourdes Lopez, Partner at Boyden Spain shares senior recruitment advice, “Top talent in the technology and tech-driven sectors will be attracted to human-centric companies offering innovation, creativity and a strong strategy for facing new challenges. This is a key moment for reinforcing leadership teams. Top executives are more open to disruptive projects and will do proper due-diligence before joining. So transparent and clear communication from the early stages is essential, as well as a good understanding of candidates’ main motivations.”

Findings on how organisations are approaching ESG show that for 60 percent of respondents ESG-sustainability is ‘part of most business discussions’ or ‘deeply embedded in organisational culture’; and for 51 percent of respondents ESG-DE&I is ‘part of most business discussions’ or ‘deeply embedded in organisational culture’.

ESG is very much a focus and priority at board level. Exploring skills most in need of strengthening on the board shows (i) 60 percent of respondents identify ESG-DE&I; (ii) 50 percent ESG-sustainability; and (iii) 47 percent innovation/business transformation.

Read the full report: Europe Regional Analysis: Strengthening the human-centric core of Industry 5.0

About the research

This research was conducted in Q2 2022 among senior executives worldwide from publicly-quoted, private/independent, private/family owned, social enterprise and PE-backed organisations. A total of 640 complete responses include 33 percent from Europe, where respondents are 31 percent board/president/CEOs; 21 percent SVP, division or country heads; and 40 percent functional leaders.

About Boyden

Boyden is a premier leadership and talent advisory firm with more than 75 offices in over 45 countries. Our global reach enables us to serve client needs anywhere they conduct business. We connect great companies with great leaders through executive search, interim management and leadership consulting solutions. For further information, visit www.boyden.com.

Contact:

Joanna Goncalves, Boyden
Global Senior Director of Marketing
T: +1 416 214 4208
E: jgoncalves@boyden.com


1 The Fifth Industrial Revolution, also known as Industry 5.0, is a new phase of industrialisation, whereby humans work alongside advanced technologies and AI-powered robots to enhance processes within the workplace. Source: The Manufacturer. Source: https://www.themanufacturer.com/articles/the-innovation-behind-the-industrial-revolution/

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/101b0304-75d8-4702-8581-4ced62fa391f

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 20228.12.2022 22:30:00 CET | Press release

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of sharesTotal number of voting rights11/30/2022 94,137,145 Total gross of voting rights: 94,137,145 Total net* of voting rights: 93,966,891 * Total net = total number of voting rights attached to shares – shares without voting rights Attachment PDF Version

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants8.12.2022 22:00:00 CET | Press release

Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 64,919 divided into 64,919 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand Pharma's employee warrant programs. Employee warrant programs are part of Zealand Pharma’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand Pharma share at a prespecified price, the exercise price, in specific predefined time periods before expiration. For a more detailed description of Zealand Pharma’s warrant programs, see the company’s Articles o

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such8.12.2022 21:40:00 CET | Press release

COPENHAGEN, Denmark, December 8, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associateda)NamePaul Chaplin2.Reason for the notificationa)Position/status President and Chief Executive Officer of Bavarian Nordic A/S b)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitora)NameBavarian Nordic A/Sb)LEI2138006JCDVYIN6INP514.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducteda)Description of the financial instrument, type of instrument Identification codeWarrants DK0015

Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer8.12.2022 21:40:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse. 1.Nærmere oplysninger om personen med ledelsesansvar/personen med nær tilknytning til dennea)NavnPaul Chaplin2.Årsag til indberetningena)Stilling/titelAdministrerende direktør i Bavarian Nordic A/Sb)Første indberetning/ændringFørste indberetning3.Nærmere oplysninger om udstederen, deltageren på markedet for emissionskvoter, auktionsplatformen, auktionsholderen eller den auktionstilsynsførendea)NavnBavarian Nordic A/Sb)LEI-kode2138006JCDVYIN6INP514.Nærmere oplysninger om transaktionen/transaktionerne: gentages for i) hver type instrument, ii) hver type transaktion, iii) hver dato og iv) hvert sted, hvor der er udført transaktionera)Beskrivelse af det finansielle instrument, instrumenttypen IdentifikationskodeTegningsoption

Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere8.12.2022 21:35:00 CET | pressemeddelelse

KØBENHAVN, Danmark, 8. december 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at udstede tegningsoptioner til koncernledelsen og udvalgte medarbejdere i Bavarian Nordic koncernen. Som et nyt initiativ vil erhvervelsen (vesting) af tegningsoptioner for medlemmer af koncernledelsen være baseret på succesfuld opnåelse af relevante Key Performance Indicators (KPI’er). Beslutningen er truffet i henhold til generalforsamlingens bemyndigelser til bestyrelsen, jf. vedtægternes § 5b og 5c, og i overensstemmelse med selskabets vederlagspolitik. Der tildeles i alt 248.787 tegningsoptioner til medlemmer af koncernledelsen til en udnyttelseskurs på DKK 224,70 pr. aktie, svarende til markedskursen for Bavarian Nordics aktie på tildelingstidspunktet. Erhvervelse af tegningsoptionerne er betinget af forudgående opfyldelse af KPI’er, som fastsættes af bestyrelsen. Der tildeles i alt 683.264 tegningsoptioner til udvalgte medarbejdere i Bavarian Nordic koncernen til